H.L. Ormond & Company’s Vertex Pharmaceuticals VRTX Stock Holding History

H.L. Ormond & Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$329K	Buy
2022 Q2	$267K	Sell
2022 Q1	$348K	Sell
2021 Q4	$323K	Buy